Search for:
International

International: HCLS Webinar Series – Lessons from COVID-19: Compulsory licensing in a new world

By 1 Min Read

In brief

The Baker McKenzie Healthcare & Life Science Industry Group presented the first of a series of short webinars sharing legal industry insights and providing practical guidance in the context of today’s evolving world. On 17-18 November 2020, the session focused on a region-by-region view of the evolving compulsory licensing regimes during the COVID-19 pandemic.

The 60-minute session featured a region-by-region look at the evolving compulsory licensing regimes and how they are being shaped by the pandemic. With the mounting global pressure to secure vaccines in development and drugs showing promise as possible COVID-19 treatments, our speakers shared practical insights and updates on the compulsory licensing trends and regulations likely to affect companies across Asia Pacific; Europe, the Middle East and Africa; Latin America*; and North America.

View the recorded webinar.

Download the material.

*******

Series link for registration.

*In cooperation with Trench Rossi Watanabe, a Brazilian law firm

Categories:
Author

Hiroshi Sheraton's practice covers all aspects of intellectual property law with a particular emphasis on contentious patent and trade mark matters and life sciences. Much of his work is cross-border in nature. He regularly co-ordinates pan-European and global IP litigation and advises clients on international IP strategies for patent litigation and brand protection. He represents clients in the UKIPO, EPO, OHIM, the English Courts and the CJEU. He has experience of IP matters across Europe and has litigated IP cases in Germany, France, Spain, Italy, the Netherlands, Belgium, Austria, Ireland, Northern Ireland and Luxembourg, the USA and Asia Pacific. Although he has a first degree in biochemistry and molecular biology, he covers all areas of technology from pharmaceuticals/biotech products and agrochemicals to electronics and software.

Author

Marcela Trigo de Souza joined the Firm in 2014 as a partner in the group of Intellectual Property and Information Technology and Communications, acting with focus on litigation and strategic advisory. She is currently Head of the Life Sciences Industry Group and Healthcare. Marcela has extensive experience in legal disputes involving patents, industrial secrecy, protection of confidential data, data package exclusivity (DPE), unfair competition and regulatory compliance, especially in the pharmaceutical, biotechnology and telecommunications areas.
*Trench Rossi Watanabe and Baker McKenzie have executed a strategic cooperation agreement for consulting on foreign law.

Author

Elisabeth White is a partner in Baker McKenzie's Sydney office. Elisabeth has over 15 years' experience as an intellectual property and regulatory advisor, focusing upon IP protection and enforcement with a particular emphasis on regulated industries and related disputes. Elisabeth is described in Asia Pacific Legal 500 as providing “decisive expert opinion and a pragmatic approach”. She has been featured in Best Lawyers - Intellectual Property listed annually since 2013.

Related Posts